secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0001193125-22-175515
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology annual meeting results: two directors re-elected, Say-on-Pay approved, KPMG ratified
--------------------------------------------------------------------------------

- Itziar Canamasas and Jack Nielsen reelected as Class II directors with 31,224,326 and 27,509,300 votes for respectively.
- Advisory Say-on-Pay proposal approved (28,566,208 for, 3,738,258 against, 8,032 abstain).
- Stockholders selected every year for frequency of future Say-on-Pay votes (32,294,203 votes for every year).
- Ratification of KPMG LLP as independent auditor for fiscal 2022 approved (34,268,632 for, 643 against, 1,668 abstain).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000119312522175515/0001193125-22-175515-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000119312522175515/d350279d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-175515

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer